| Over a month ago | ||||
CIBC analyst Scott… CIBC analyst Scott Fletcher raised the firm's price target on Dialogue Health to C$4 from C$3.50 and keeps a Neutral rating on the shares. | ||||
TD Securities raised the… TD Securities raised the firm's price target on Dialogue Health to C$4 from C$3.25 and keeps a Hold rating on the shares. | ||||
| Over a quarter ago | ||||
National Bank analyst… National Bank analyst Endri Leno lowered the firm's price target on Dialogue Health to C$6.25 from C$6.75 and keeps an Outperform rating on the shares. | ||||
Desjardins analyst Jerome… Desjardins analyst Jerome Dubreuil lowered the firm's price target on Dialogue Health to C$5 from C$7.50 and keeps a Buy rating on the shares. | ||||
Canaccord analyst Doug… Canaccord analyst Doug Taylor lowered the firm's price target on Dialogue Health to C$5 from C$6 and keeps a Speculative Buy rating on the shares. | ||||
National Bank analyst… National Bank analyst Endri Leno lowered the firm's price target on Dialogue Health to C$6.75 from C$8.50 and keeps an Outperform rating on the shares. | ||||
Scotiabank analyst Adam… Scotiabank analyst Adam Buckham lowered the firm's price target on Dialogue Health to C$5.50 from C$8 and keeps an Outperform rating on the shares. | ||||
RBC Capital analyst… RBC Capital analyst Douglas Miehm lowered the firm's price target on Dialogue Health to C$5 from C$6 and keeps a Sector Perform rating on the shares. | ||||
Canaccord analyst Doug… Canaccord analyst Doug Taylor lowered the firm's price target on Dialogue Health to C$6 from C$8 and keeps a Speculative Buy rating on the shares. | ||||
TD Securities analyst… TD Securities analyst David Kwan lowered the firm's price target on Dialogue Health to C$3.50 from C$4.50 and keeps a Hold rating on the shares. | ||||
